This episode is brought to you by SAPRO Consulting PTY Ltd https://www.saproconsulting.com.au/

Dr Chris Wynne is the Chief Scientific Officer at New Zealand Clinical Research (NZCR). Chris has had a career of giant proportions in Clinical Research, and has been involved in a wide range of trials, including the early trials that laid the groundwork for the function cure of Hepatits C, down to the Pharmacokinetic studies for Juul - the infamous flagship vaping product of the late 2010s.

In today’s episode you can expect to learn:

• What makes NZ a great place to do Clinical Research
• Why the language of Clinical Research, and science more broadly, doesn’t translate well into marketing
• Chris’s hopes for the future of Clinical Research in NZ and abroad
• Much much more...

Always great to speak with Captains of Industry, and Chris fits that description all too well. We need to capture the hearts and minds of more talented individuals to create products that will serve our populations in the future.

You can find out more about Dr Wynne and NZCR Here:
https://www.linkedin.com/in/chris-wynne-b0414241/
https://www.linkedin.com/company/nzcr-christchurch/
https://www.nzcr.co.nz/
#research #clinicalresearch #clinicalresearchassociate #healthcare #research #pharmaceuticals #podcast #podcasts #medicine #medicalresearch